Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
boston top stories
cancer
3
×
life sciences
national blog main
clinical trials
national top stories
new york blog main
adeno-associated virus
avapritinib
blueprint medicines
cancer drugs
capmatinib
chemotherapy
cisplatin
codiak biosciences
cutaneous t-cell lymphoma
decibel therapeutics
eli lilly
europe blog main
europe top stories
exosome
gastrointestinal stromal tumors
gene therapy
genentech
hearing loss
indiana blog main
indiana top stories
jazz pharmaceuticals
joe burns
laurence reid
life science
medullary thyroid cancer
non-small cell lung cancer
novartis
pralsetinib
regenerative medicine
regeneron pharmaceuticals
What
medicines
3
×
adding
address
ago
aiming
approval
approves
balance
based
begin
biosciences
bio’s
blueprint
brings
bubbles
build
cancer
carries
cells
certain
class
clinical
codiak
decibel
designed
drug
drugs
emerged
exosome
exosomes
fda
focus
formed
forms
fund
genetic
hearing
ipo
latest
loss
Language
unset
Current search:
boston
×
cancer
×
medicines
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
